Payne H - Search Results

1

Chemotherapy at First Diagnosis of Advanced Prostate Cancer - Revolution or Evolution? Findings from a British Uro-oncology Group UK Survey to Evaluate Oncologists' Views on First-line Docetaxel in Combination with Androgen Deprivation Therapy in Castrate-sensitive Metastatic and High-risk/Locally Advanced Prostate Cancer.

Davda R, Hughes S, Jones R, Crabb SJ, Troup J, Payne H. Davda R, et al. Among authors: payne h. Clin Oncol (R Coll Radiol). 2016 Jun;28(6):376-85. doi: 10.1016/j.clon.2016.01.006. Epub 2016 Feb 11. Clin Oncol (R Coll Radiol). 2016. PMID: 26874654 Free article. Afrikaans, English.

2

First report of an isolated jejunal seminoma: presentation with melaena and iron deficiency anaemia.

Brown RS, Yassin J, Colville DH, Harland SJ, Payne HA. Brown RS, et al. Among authors: payne ha. Clin Oncol (R Coll Radiol). 2001;13(6):455-7. doi: 10.1053/clon.2001.9313. Clin Oncol (R Coll Radiol). 2001. PMID: 11824886

3

Differences and commonalities in the management of locally advanced prostate cancer: results from a survey of oncologists and urologists in the UK.

Payne HA, Gillatt DA. Payne HA, et al. BJU Int. 2007 Mar;99(3):545-53. doi: 10.1111/j.1464-410X.2006.06651.x. BJU Int. 2007. PMID: 17407513

4

Management of locally advanced prostate cancer.

Payne H. Payne H. Asian J Androl. 2009 Jan;11(1):81-7. doi: 10.1038/aja.2008.9. Epub 2008 Dec 1. Asian J Androl. 2009. PMID: 19050683 Free PMC article. Review.

5

Androgen deprivation therapy as adjuvant/neoadjuvant to radiotherapy for high-risk localised and locally advanced prostate cancer: recent developments.

Payne H, Mason M. Payne H, et al. Br J Cancer. 2011 Nov 22;105(11):1628-34. doi: 10.1038/bjc.2011.385. Epub 2011 Oct 18. Br J Cancer. 2011. PMID: 22009028 Free PMC article. Review.

6

Optimizing the care of patients with advanced prostate cancer in the UK: current challenges and future opportunities.

Payne H, Bahl A, Mason M, Troup J, De Bono J. Payne H, et al. BJU Int. 2012 Sep;110(5):658-67. doi: 10.1111/j.1464-410X.2011.10886.x. Epub 2012 Mar 19. BJU Int. 2012. PMID: 22429837

7

Increased survival with enzalutamide in prostate cancer after chemotherapy.

Scher HI, Fizazi K, Saad F, Taplin ME, Sternberg CN, Miller K, de Wit R, Mulders P, Chi KN, Shore ND, Armstrong AJ, Flaig TW, Fléchon A, Mainwaring P, Fleming M, Hainsworth JD, Hirmand M, Selby B, Seely L, de Bono JS; AFFIRM Investigators. Scher HI, et al. N Engl J Med. 2012 Sep 27;367(13):1187-97. doi: 10.1056/NEJMoa1207506. Epub 2012 Aug 15. N Engl J Med. 2012. PMID: 22894553 Free article. Clinical Trial.

8

Hormone therapy for radiorecurrent prostate cancer.

Payne H, Khan A, Chowdhury S, Davda R. Payne H, et al. World J Urol. 2013 Dec;31(6):1333-8. doi: 10.1007/s00345-012-0952-8. Epub 2012 Sep 21. World J Urol. 2013. PMID: 22996761 Review.

9

Radical radiotherapy for high-risk prostate cancer in older men.

Payne HA, Hughes S. Payne HA, et al. Oncologist. 2012;17 Suppl 1(Suppl 1):9-15. doi: 10.1634/theoncologist.2012-S1-09. Oncologist. 2012. PMID: 23015680 Free PMC article.

10

Nasty or Nice? Findings from a UK Survey to evaluate the impact of the National Institute for Health and Clinical Excellence (NICE) clinical guidelines on the management of prostate cancer.

Payne H, Clarke N, Huddart R, Parker C, Troup J, Graham J. Payne H, et al. Clin Oncol (R Coll Radiol). 2013 Mar;25(3):178-89. doi: 10.1016/j.clon.2012.09.001. Epub 2012 Oct 15. Clin Oncol (R Coll Radiol). 2013. PMID: 23079099

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

411 results

Search Page